FIELD: medicine, pharmaceutics.
SUBSTANCE: present group of inventions refers to medicine, namely therapy, and concerns treating bacterial infections. That is ensured by a combined drug containing an activated potentiated form of human gamma-interferon (IFN-γ) antibodies, an activated potentiated form of CD4 receptor antibodies and an activated potentiated form of histamine antibodies.
EFFECT: invention provides the effective treatment of bacterial infections due to potentiating the antibacterial action of the activated potentiated forms of gamma-interferon antibodies.
11 cl, 1 ex, 1 tbl
